FactaeThe Factual News

Sandoz aims for ambitious growth but hindered by US tariffs

Swiss pharmaceutical group Sandoz plans to double its revenue within ten years.

Published 2h1 sourceNotable
Lire en français
16s

The fact

The lack of a US production site hampers its growth ambitions.

US tariffs remain a significant obstacle.

Click the link to read an article on the topic:
Explore this topic
What if you saw the whole news differently?Factae cross-checks hundreds of sources worldwide to keep only the fact, no opinion. Explore the front page.
Suisse · © OpenStreetMap, OpenMapTiles, OpenFreeMapWorld map →
Follow topic →
Auto-synthesis from 1 media source · identified on September 8, 2026
Back to home
Discover

Read more

All monde →